IPA lobbies Congress to add specialty pharmacy transparency language to pending pharmacy benefit manager (PBM) reform legislationInfusion Providers Alliance2023-07-25T12:54:41+00:00Read More
IPA endorses legislation to address unsustainable cuts to the Medicare Physician Fee ScheduleInfusion Providers Alliance2023-11-28T14:37:30+00:00Read More
The IPA has cosigned a May 30 letter to Senate and House leadership asking Congress to amend the Inflation Reduction Act by making “providers whole in Medicare’s drug price negotiation process and removing them from the middle of this negotiation process.”Infusion Providers Alliance2023-06-09T18:08:21+00:00Read More
IPA submits hearing testimony to House subcommittee on legislation addressing transparency and competition in health careInfusion Providers Alliance2023-11-29T16:35:56+00:00Read More
7 Provider Organizations Co-sign Letter to CMS Administrator RE: MAC Downcoding of Highly Complex Drug InfusionsInfusion Providers Alliance2022-08-30T22:37:12+00:00Read More
IPA Supports Amendment to Protect Infusion Providers and their Patients from Rx Pricing Provisions of Senate Reconciliation BillInfusion Providers Alliance2022-08-05T14:24:52+00:00Read More